J. Caicedo Valle, M. C. Berrouet Mejía, and J. C. Saldarriaga Giraldo, “The risk of 2,5-dimethoxy-4-bromophenylethylamine (2C-B): Case series”, Med UPB, vol. 35, no. 2, pp. 139–143, Dec. 2016, doi: 10.18566/medupb.v35n2.a08.